Pharmaceuticals procurement in Bangladesh

Towards systematic governance reform of procurement for Pharma products

Download the research summary.

Research question:

The excess profits of the top companies allow them to market their drugs as ‘better’ drugs, by funding grey or illicit payments to doctors to prescribe these expensive drugs. Our research will map how the economics of this process works, and we will go further and use testing facilities at the London School of Hygiene & Tropical Medicine to show that from a pharmacological point of view there is no difference between the more expensive and cheaper versions of the same drugs.

Project summary:

Pharmaceuticals are a complex and large sector in Bangladesh with significant corruption and health impacts. If successful, this project will stop the top companies paying doctors to prescribe their brands for these particular molecules because there will no longer be excess profits in these areas. In an incremental way, this strategy could expand the market for the smaller pharmaceutical companies by squeezing out a damaging type of rent-seeking and thereby reducing out-of pocket expenditures for the poor.

SOAS will undertake two projects and a laboratory-based experiment in the pharmaceutical sector. The motivation of the interrelated projects is to provide a joined-up analysis that seeks to increase competition in the sector as a way of reducing corruption and reducing prices for poor consumers.

The first project led by Transparency International Bangladesh will identify the weaknesses of the regulatory structure and the most feasible points of entry. Our second project led by the James P Grant School of Public Health (JPGSPH) of BRAC University will complement this to look at the economics of the pharmaceutical sector and map how the top companies effectively bribe doctors to prescribe particular brands whose prices are higher.

Our hypothesis is that the higher prices that the top companies charge for their version of identical drugs that are available from other manufacturers allow them to pay and influence doctors to prescribe their brands, thereby closing the circuit of rent capture.

Main Partners:  Transparency International Bangladesh, The London School of Hygiene and Tropical Medicine (LSHTM) and James P Grant School of Public Health (JPGSPH) of BRAC University.

Read the full project summary.

Other projects

Electricity in Bangladesh

Productive investments in the power generation sector have been minimal, while less efficient and more costly investments have multiplied. There has been significant corruption through rent capture be...

Read more

Climate Change in Bangladesh

As a developing country subject to potentially serious damage as a result of climate change, Bangladesh has received significant subsidies from development partners to invest in adaptation and mitigat...

Read more

Skills in Bangladesh

Overall, the performance of skills training programmes in Bangladesh has been poor. But some targeted programmes have done well because they have addressed relevant market failures with targeted fundi...

Read more

Business Groups in Bangladesh

This cross-country project will trace the evolution of such local firms and analyse their impact on growth in their respective sectors. It will attempt to isolate proactive policy from their experienc...

Read more

Health Providers in Bangladesh

Health systems in many countries create incentives for health workers to engage in corrupt practices that lead to inappropriate and ineffective care, leading to high costs and poor outcomes for those ...

Read more